February 15, 2017
A New Jersey federal judge on Wednesday found that Dr. Reddy's Laboratories Inc.'s planned generic version of Helsinn Healthcare SA's anti-nausea drug Aloxi infringes three patents for the drug and rejected Dr. Reddy's contention that two of those patents are invalid.
May 14, 2012
Roche Palo Alto LLC and Helsinn Healthcare SA on Friday hit Dr. Reddy's Laboratories Ltd. with a patent infringement suit challenging the rival drugmaker's attempt to get U.S. approval of a generic version of their anti-nausea medication Aloxi.